Loading clinical trials...
Loading clinical trials...
Non-inferiority, Phase III Clinical Trial Comparing Dapaconazole Cream 2% (Biolab Sanus Farmacêutica Ltda.) Versus Ketoconazole Cream 2% (Nizoral® Janssen-Cilag) in Patients With Tinea Pedis
Conditions
Interventions
Dapaconazole
Ketoconazole
Locations
1
Brazil
Clínica Gobbato de Dermatologia
Rio Claro, São Paulo, Brazil
Start Date
June 1, 2016
Primary Completion Date
December 1, 2016
Last Updated
February 1, 2017
NCT07245667
NCT00233493
NCT03129321
NCT03897257
NCT01891305
NCT03135912
Lead Sponsor
Biolab Sanus Farmaceutica
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions